Cardiome Pharma Corp (NASDAQ:CRME)

Delayed Data
As of 9:32am ET
 +0.01 / +0.11%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 11.07, with a high estimate of 16.00 and a low estimate of 5.00. The median estimate represents a +21.40% increase from the last price of 9.12.

Chart unavailable

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 32.61%
Growthannually 71.88%


Growthquarterly 39.05%
Growthannually 8.72%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account